ABSI
Price
$2.76
Change
-$0.10 (-3.50%)
Updated
Nov 20, 04:59 PM (EDT)
Capitalization
415.03M
123 days until earnings call
Intraday BUY SELL Signals
KYMR
Price
$64.52
Change
-$0.30 (-0.46%)
Updated
Nov 20, 04:59 PM (EDT)
Capitalization
4.64B
91 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ABSI vs KYMR

Header iconABSI vs KYMR Comparison
Open Charts ABSI vs KYMRBanner chart's image
Absci
Price$2.76
Change-$0.10 (-3.50%)
Volume$51.52K
Capitalization415.03M
Kymera Therapeutics
Price$64.52
Change-$0.30 (-0.46%)
Volume$4.99K
Capitalization4.64B
ABSI vs KYMR Comparison Chart in %
ABSI
Daily Signal:
Gain/Loss:
KYMR
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ABSI vs. KYMR commentary
Nov 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABSI is a Hold and KYMR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 21, 2025
Stock price -- (ABSI: $2.76 vs. KYMR: $64.52)
Brand notoriety: ABSI and KYMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABSI: 103% vs. KYMR: 83%
Market capitalization -- ABSI: $415.03M vs. KYMR: $4.64B
ABSI [@Biotechnology] is valued at $415.03M. KYMR’s [@Biotechnology] market capitalization is $4.64B. The market cap for tickers in the [@Biotechnology] industry ranges from $107.15B to $0. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABSI’s FA Score shows that 0 FA rating(s) are green whileKYMR’s FA Score has 0 green FA rating(s).

  • ABSI’s FA Score: 0 green, 5 red.
  • KYMR’s FA Score: 0 green, 5 red.
According to our system of comparison, ABSI is a better buy in the long-term than KYMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABSI’s TA Score shows that 5 TA indicator(s) are bullish while KYMR’s TA Score has 4 bullish TA indicator(s).

  • ABSI’s TA Score: 5 bullish, 6 bearish.
  • KYMR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, KYMR is a better buy in the short-term than ABSI.

Price Growth

ABSI (@Biotechnology) experienced а +4.55% price change this week, while KYMR (@Biotechnology) price change was +1.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.65%. For the same industry, the average monthly price growth was -7.08%, and the average quarterly price growth was +60.39%.

Reported Earning Dates

ABSI is expected to report earnings on Mar 24, 2026.

KYMR is expected to report earnings on Feb 19, 2026.

Industries' Descriptions

@Biotechnology (-1.65% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($4.64B) has a higher market cap than ABSI($415M). KYMR YTD gains are higher at: 60.378 vs. ABSI (5.344). ABSI has higher annual earnings (EBITDA): -100.08M vs. KYMR (-267.03M). KYMR has more cash in the bank: 665M vs. ABSI (117M). ABSI has less debt than KYMR: ABSI (7.41M) vs KYMR (85.7M). KYMR has higher revenues than ABSI: KYMR (44.7M) vs ABSI (4.14M).
ABSIKYMRABSI / KYMR
Capitalization415M4.64B9%
EBITDA-100.08M-267.03M37%
Gain YTD5.34460.3789%
P/E RatioN/AN/A-
Revenue4.14M44.7M9%
Total Cash117M665M18%
Total Debt7.41M85.7M9%
TECHNICAL ANALYSIS
Technical Analysis
ABSIKYMR
RSI
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 4 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 2 days ago
76%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend about 1 month ago
87%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 7 days ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 2 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
ABSI
Daily Signal:
Gain/Loss:
KYMR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NNLEX22.96N/A
N/A
Nicholas Limited Edition N
FRCSX60.24N/A
N/A
Franklin Small Cap Value R6
HLHIX30.33N/A
N/A
Virtus KAR Health Sciences Inst
LYRBX28.78N/A
N/A
Lyrical US Value Equity Investor
RNWHX93.04-1.18
-1.25%
American Funds New World R5E

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with NRIX. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
-0.46%
NRIX - KYMR
64%
Loosely correlated
+6.98%
VERA - KYMR
61%
Loosely correlated
-2.38%
IDYA - KYMR
54%
Loosely correlated
+0.09%
RGNX - KYMR
54%
Loosely correlated
-0.59%
NUVL - KYMR
54%
Loosely correlated
+0.90%
More